Prion Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The prion protein (PrP), encoded by the PRNP gene, is a glycosylphosphatidylinositol (GPI)-anchored protein that is central to prion diseases. Prions are misfolded proteins that can propagate their abnormal conformation to normal cellular prion proteins, causing a chain reaction leading to neurodegeneration. Prion diseases include Creutzfeldt-Jakob disease (CJD), variant CJD (vCJD), fatal familial insomnia (FFI), and Gerstmann-Sträussler-Scheinker syndrome (GSS).
| Attribute |
Value |
| Gene Symbol |
PRNP |
| Protein Name |
Major prion protein (PrPc) |
| Alternative Names |
PrP27-30, PrP33-35 |
| HGNC ID |
HGNC:9444 |
| Entrez Gene ID |
5622 |
| UniProt ID |
P04156 |
¶ Domain Architecture
The prion protein consists of:
- N-terminal signal peptide (1-23): Targets protein to secretory pathway
- PrP-specific region (24-111): Contains octarepeat region
- Central hydrophobic region (106-126): Critical for prion formation
- C-terminal GPI anchor signal (231-253): For membrane attachment
- α-helices: Three α-helices (144-154, 173-194, 200-228)
- β-sheets: Two β-strands (128-131, 161-164)
- Disulfide bond: Between Cys179 and Cys214
- Copper binding sites: Octarepeat region binds Cu2+
The same amino acid sequence can adopt different conformations (prion strains), leading to different disease phenotypes. Strain diversity is encoded in the three-dimensional structure of the misfolded protein (PrPSc).
The cellular prion protein (PrPc) is expressed predominantly in the central nervous system but also in peripheral tissues. Its normal function remains incompletely understood but includes:
- Synaptic function: Involved in synaptic transmission and plasticity
- Copper ion binding: May regulate copper homeostasis
- Neuroprotection: Anti-apoptotic and antioxidant properties
- Cell signaling: Interacts with various ligands and receptors
- Myelin maintenance: Supporting oligodendrocyte function
The scrapie isoform (PrPSc) is the infectious, misfolded form that:
- Forms amyloid fibrils: Aggregates into insoluble fibrils
- Recruits normal PrPc: Templates conversion to PrPSc
- Causes neuronal loss: Through toxicity and synaptic dysfunction
- Creates vacuolation: Leading to spongiform changes
- Forms amyloid plaques: In some prion diseases
| Disease |
Type |
Key Features |
| Creutzfeldt-Jakob Disease (CJD) |
Sporadic/Familial/Acquired |
Rapid progression, dementia, ataxia |
| Variant CJD (vCJD) |
Acquired (BSE) |
Psychiatric symptoms, young onset |
| Fatal Familial Insomnia (FFI) |
Genetic |
Sleep disturbance, autonomic dysfunction |
| GSS Syndrome |
Genetic |
Cerebellar ataxia, long duration |
| Kuru |
Acquired |
Forebrain degeneration |
Prion protein pathology is observed in:
- Alzheimer's Disease: PrP interacts with Aβ oligomers
- Parkinson's Disease: PrP may modulate α-synuclein toxicity
- Anti-prion compounds: Quinacrine, pentosan polysulfate
- Immunotherapy: Antibodies targeting PrPSc
- Gene silencing: ASOs targeting PRNP expression
- Stabilizing agents: Compounds stabilizing PrPc structure
- Copper chelators: Modulating copper-binding dynamics
- Several clinical trials for anti-prion compounds are ongoing
- ASO-based approaches showing promise in preclinical models
- Prnp knockout mice: Viable with mild neurological phenotypes
- Transgenic mice: Expressing mutant PRNP to model disease
- ** hamster/ovine models**: For studying scrapie and BSE
The study of Prion Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- PMID:10863724 - Prion protein structure and function
- PMID:11719799 - Molecular mechanisms of prion propagation
- PMID:12520019 - Prion diseases: molecular basis and therapeutic approaches
- PMID:14627608 - PrP and copper binding
- PMID:16251367 - Prion protein in synaptic function
- PMID:18599488 - Anti-prion therapies in development
- PMID:21107011 - Strain diversity in prions
- PMID:25601767 - Prion diseases and Alzheimer's disease overlap